Table 4.

Therapy response

		LDMC	CCT	p
		n = 40	n = 80
DCR (n (%))		12 (30.0%)	18 (22.5%)	0.380
Therapy response after 24 weeks	PD	28 (70.0%)	62 (77.5%)
	SD	5 (12.5%)	15 (18.8%)
	PR	6 (15.0%)	3 (3.8%)
	CR	1 (2.5%)	0 (0.0%)
Median PFS (range) (weeks)		12.0 (6–86)	12.0 (4–100)	0.218
Median duration of response (range) (weeks)		31.0 (12–74)	20.5 (12–88)	0.383
Therapy response (n (%))		15 (37.5%)	24 (30.0%)	0.417

DCR Disease Control Rate, PFS progression-free survival, PD progression disease, SD stable disease, PR Partial response, CR Complete response